Detection of molecular targets on the surface of CD34+/CD38− stem cells in various myeloid malignancies
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 47 (2), 207-222
- https://doi.org/10.1080/10428190500272507
Abstract
Recent data suggest that myeloid neoplasms are organized hierarchically in terms of self-renewal and maturation of early progenitor cells, similar to normal myelopoiesis. In acute myeloid leukemia (AML), the NOD/SCID mouse-repopulating leukemic stem cells usually co-express CD123 with CD34, but lack CD38. So far, however, little is known about expression of other markers and targets on these progenitors. In the present study, expression of target antigens on CD34+/CD38− cells was analysed by multi-color flow cytometry in patients with AML (n = 18), myelodysplastic syndromes (MDS, n = 6), chronic myeloid leukemia (CML, n = 8) and systemic mastocytosis (SM, n = 9). The IL-3Rα chain (CD123) was found to be expressed on CD34+/CD38− cells in a majority of the patients in all disease categories. Independent of the type of disease, the vast majority of these stem cells co-expressed aminopeptidase-N (CD13) and CD44 in all patients. By contrast, the CD34+/CD38− progenitor cells expressed variable amounts of the target receptor CD33, c-kit (CD117) and AC133 (CD133). In conclusion, neoplastic stem cells in various myeloid neoplasms appear to express a similar phenotype including target antigens such as CD13, CD33 and CD44. Since many of these targets are not expressed on all stem cells in all patients, the elimination of the entire clone may require combinations of targeted antibodies or use of additional drugs.Keywords
This publication has 47 references indexed in Scilit:
- Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human diseaseLeukemia, 2005
- The Effect of Anti-CD44 Monoclonal Antibodies on Differentiation and Proliferation of Human Acute Myeloid Leukemia CellsLeukemia & Lymphoma, 2004
- Human leukaemic stem cells: a novel target of therapyEuropean Journal of Clinical Investigation, 2004
- Engraftment of NOD/SCID-β2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndromeBlood, 2004
- CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1Blood, 2004
- Chronic Myelogenous Leukemia and Myeloproliferative DiseaseHematology, 2004
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaThe New England Journal of Medicine, 2003
- Chronic Myelogenous LeukemiaHematology, 2002
- Betulinic Acid Inhibits Aminopeptidase N ActivityPlanta Medica, 1998
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997